It was learned through implant patient registry and investigation that a 23mm 3300tfx aortic valve was explanted after an implant duration of 9 years, 3 months due to patient prosthesis mismatch and abnormal gradient.The explanted valve was replaced with a 25mm 11500a valve.Per medical records, the patient presented with progressive fatigue and shortness of breath.Or tee showed mild valvular aortic stenosis and the gradient is abnormal this prosthetic valve.He underwent redo minimally invasive avr, aortic root enlargement, replacement of the supra-coronary ascending aorta and hemiarch with a 26mm hemashield graft and a 25mm 11500a valve were implanted.Post-procedure tee showed a well-seated valve leaflets opening, no pvl, and mg of 7.On pod #3, the patient was discharged home in good condition.Edwards lifesciences maintains an implant patient registry.This registry is a patient tracking mechanism for serialized edwards implantable devices (bioprosthetic heart valves and annuloplasty rings), rather than a true post-market surveillance registry.Through the registry, edwards is notified when these devices are implanted.In addition, patient and/or device status may be reported to the registry via the implantation data cards.The information is received from various sources (e.G.Surgeon, hospital, and patient family members) and is not received in the form of a conventional 'customer complaint'.The information reported may or may not be related to the edwards device.
|
H10: additional manufacturer narrative: the investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
|